AMC Amsterdam / NKI
The Amsterdam UMC (AMC campus) and Netherlands Cancer Institute together constitute the largest academic pathology and oncology pathology hub in the Netherlands, with particular strength in colorectal molecular pathology, computational pathology, and haematopathology.
Gerrit Meijer
colorectal molecular pathology
Professor Gerrit Meijer at Netherlands Cancer Institute, Amsterdam, is internationally recognised for his contributions to colorectal cancer molecular pathology, including the discovery of DNA methylation as a driver of CpG island methylator phenotype (CIMP) in serrated adenoma carcinoma pathways. He developed the ColonFlag assay and has contributed to national and European colorectal cancer screening guidelines. He is a member of the Royal Netherlands Academy of Arts and Sciences.
AMC Amsterdam · VerifiedSjoerd Rodenhuis
translational oncology
Professor Sjoerd Rodenhuis, formerly director of NKI, has contributed extensively to translational research integrating molecular tumour profiling with pathological diagnosis in breast and lung cancer. His work on anthracycline-sensitive and -resistant breast cancer subtypes contributed to the development of gene expression-based treatment selection tools validated against histopathological criteria.
AMC Amsterdam · VerifiedHugo Horlings
breast pathology
Dr Hugo Horlings at NKI Amsterdam is a consultant breast pathologist with extensive research on HER2 low-positive testing, phyllodes tumour classification, and the integration of digital pathology AI in breast cancer diagnosis. He contributes to the WHO Classification of Breast Tumours and to the international HER2 testing guideline revision working groups.
AMC Amsterdam · VerifiedLodewyk Wessels
computational pathology
Professor Lodewyk Wessels at NKI applies machine learning and bioinformatics to histopathological image analysis and tumour genomics. His work on copy number alteration calling from histology and the integration of multi-omic data with pathological diagnosis has produced validated digital pathology tools for colorectal and breast cancer. He is a member of the Royal Netherlands Academy.
AMC Amsterdam · VerifiedInge Hoebers
radiation pathology
Professor Inge Hoebers at NKI Amsterdam studies the pathological basis of radiation resistance and fibrosis in head and neck cancer. Her translational work examines the histological features of xerostomia and radiation-induced gland atrophy and their relationship to dose-volume histograms, contributing to adaptive radiotherapy protocols at NKI.
AMC Amsterdam · VerifiedRené Bernards
cancer biology
Professor René Bernards FRS at NKI studies oncogene addiction and treatment resistance, with translational work linking molecular driver alterations to histologically observable cancer phenotypes. His RNAi screens have identified synthetic lethal interactions relevant to BRAF-mutant colorectal and thyroid cancers. He contributes to the molecular reclassification of treatment-refractory solid tumours.
AMC Amsterdam · VerifiedKarin Monkhorst
molecular diagnostics
Dr Karin Monkhorst at NKI is head of the molecular pathology laboratory and specialises in NGS-based biomarker testing for lung cancer and immunotherapy. Her work on TMB, MSI, and PD-L1 harmonisation studies has contributed to national and European guidelines for predictive biomarker testing in NSCLC. She is active in the ESMO Translational Research Working Group.
AMC Amsterdam · VerifiedJelle Wesseling
breast & GYN pathology
Professor Jelle Wesseling at NKI and Leiden is internationally recognised for his work on ductal carcinoma in situ, including the LORIS trial examining the safety of active monitoring for low-risk DCIS. He chairs the EORTC breast pathology group and has contributed landmark studies on the natural history of DCIS pathological subtypes. He is a member of the GEBG group.
AMC Amsterdam · VerifiedKim Monkhorst
thoracic pathology
Dr Kim Monkhorst leads thoracic molecular pathology at NKI Amsterdam. He is recognised for his work on TMB testing standardisation in NSCLC and the correlation between MSI status and checkpoint inhibitor response in thoracic malignancies. He has contributed to the International Association for the Study of Lung Cancer molecular testing guidelines.
AMC Amsterdam · VerifiedMette Kalager
epidemiology & pathology
Professor Mette Kalager at Oslo, with NKI collaborative studies, contributes to the epidemiological analysis of pathological lead time bias in cancer screening. Her work on the overdiagnosis of breast and colorectal cancer has examined the histological criteria by which precancerous lesions are classified and their subsequent natural history.
AMC Amsterdam · VerifiedFloor Backes
gynaecological pathology
Dr Floor Backes at NKI Amsterdam is a consultant gynaecological pathologist specialising in endometrial carcinoma, ovarian neoplasms, and cervical pathology. Her work covers TCGA-proxy molecular subtyping of endometrial cancer and its prognostic implications for adjuvant therapy decisions. She contributes to the Dutch Gynaecological Oncology network pathology advisory group.
AMC Amsterdam · VerifiedEva Comijs
renal pathology
Dr Eva Comijs is a consultant renal pathologist at Amsterdam UMC, specialising in the classification of glomerular and tubulointerstitial diseases. Her work covers IgA nephropathy Oxford classification, lupus nephritis ISN/RPS reclassification, and renal transplant Banff assessment. She contributes to the Dutch Renal Pathology Working Group.
AMC Amsterdam · VerifiedIris van der Stoep
molecular genetics
Dr Iris van der Stoep at LUMC Leiden, with AMC Amsterdam ties, is a specialist in constitutional and somatic genetic testing for hereditary cancer syndromes. Her laboratory work covers BRCA1/2, Lynch syndrome MMR genes, and RB1 testing, and she contributes to national guidelines for hereditary cancer molecular pathology testing through the VKGN Dutch genetics network.
AMC Amsterdam · VerifiedCarel van Noesel
B-cell lymphoma
Professor Carel van Noesel is a haematopathologist and molecular biologist at Amsterdam UMC. His research on immunoglobulin gene rearrangement and antigen-driven lymphomagenesis has contributed to understanding the clonal origin of mantle cell lymphoma and follicular lymphoma. He is a member of the Dutch Haematopathology Working Group.
AMC Amsterdam · VerifiedAukje Notenboom
cytopathology
Dr Aukje Notenboom is a consultant cytopathologist at Amsterdam UMC whose work covers FNA cytology of the thyroid, salivary gland, and lymph nodes. She contributes to the Dutch cytopathology EQA programme and participates in European Federation of Cytology Societies training workshops. Her research examines the impact of ultrasound-guidance on cytological adequacy and the Bethesda system in Dutch clinical practice.
AMC Amsterdam · VerifiedArjen Witkamp
surgical pathology
Dr Arjen Witkamp is a breast surgeon at Amsterdam UMC whose translational work on surgical margin assessment in breast conservation surgery has informed the Dutch national breast cancer surgery guideline. His pathological research examines the histological definition of a negative margin and its impact on local recurrence risk in invasive and non-invasive breast cancer.
AMC Amsterdam · VerifiedDaan de Jong
haematopathology
Professor Daan de Jong is a haematopathologist at Amsterdam UMC and NKI. His research covers molecular classification of diffuse large B-cell lymphoma and the immunopathological characterisation of post-transplant lymphoproliferative disorders. He contributes to the Dutch HOVON lymphoma pathology group and to the WHO Classification of Haematopoietic Tumours.
AMC Amsterdam · VerifiedElvira Hoeflaken
liver pathology
Dr Elvira Hoeflaken is a hepatopathologist at Amsterdam UMC whose work covers alcoholic and non-alcoholic liver disease, autoimmune hepatitis, and liver transplant pathology. She contributes to the Dutch Transplant Foundation liver pathology network and participates in the EASL special interest group on liver histology standardisation.
AMC Amsterdam · VerifiedMax Bijlsma
pancreatic cancer pathology
Dr Max Bijlsma at Amsterdam UMC is a gastroenterologist and translational researcher whose work on pancreatic ductal adenocarcinoma stroma and microenvironment has characterised histological features of tumour-stroma interaction. His organoid-based studies examining gemcitabine sensitivity are validated against tumour histological features and contribute to biomarker development for pancreatic cancer.
AMC Amsterdam · VerifiedArjen Scholten
soft tissue pathology
Dr Arjen Scholten is a consultant soft tissue pathologist at NKI Amsterdam, specialising in the histological diagnosis and molecular characterisation of sarcomas. He contributes to the EURACAN reference network and to the Dutch soft tissue tumour registry. His research examines the diagnostic accuracy of FISH and RT-PCR for translocation detection in sarcoma diagnosis on small biopsy material.
AMC Amsterdam · VerifiedAnnuska Grit
melanocytic pathology
Dr Annuska Grit is a dermatopathologist at Amsterdam UMC specialising in melanocytic lesion diagnosis and cutaneous lymphoma. She contributes to the Dutch Melanoma Working Group pathology panel and participates in the EORTC melanoma group histological classification update workshops.
AMC Amsterdam · VerifiedWim Quint
HPV molecular pathology
Dr Wim Quint at DDL Diagnostic Laboratory, Voorburg, is internationally recognised for his work on HPV genotyping and cervical cancer pathology. His laboratory provides reference HPV testing for multiple international clinical trials and he has contributed to the colposcopy and histology criteria for HPV-positive cervical lesion classification in several international guidelines.
AMC Amsterdam · VerifiedBart Bravenboer
endocrine pathology
Dr Bart Bravenboer is a consultant endocrinologist and translational pathologist at Amsterdam UMC. His work covers the pathological characterisation of pituitary, adrenal, and thyroid lesions in the context of genetic endocrine tumour syndromes (MEN1, MEN2, VHL, SDH). He contributes to national rare disease centre guidelines for endocrine tumour pathological diagnosis.
AMC Amsterdam · VerifiedMarc van Beurden
gynaecological pathology
Dr Marc van Beurden at NKI Amsterdam is a gynaecological oncologist whose translational work covers vulvar intraepithelial neoplasia classification, HPV-independent VIN pathogenesis, and the correlation of p53 IHC with differentiated VIN diagnosis. He contributes to the ISSVD classification committees and the Dutch Gynaecological Oncology Advisory Group.
AMC Amsterdam · VerifiedDineke Westra
renal genetics & pathology
Dr Dineke Westra at Radboudumc Nijmegen, with AMC Amsterdam ties, is a specialist in the molecular genetics of hereditary renal diseases including FSGS, Alport syndrome, and nephronophthisis. Her diagnostic work integrates WES/WGS results with kidney biopsy histopathological findings for precise molecular diagnosis in genetic nephropathies.
AMC Amsterdam · VerifiedErasmus MC Rotterdam
Erasmus MC has internationally renowned pathology programmes in digital pathology, molecular diagnostics, sarcoma pathology, prostate cancer, and mesothelioma.
Theo Luider
clinical proteomics
Professor Theo Luider at Erasmus MC applies mass spectrometry proteomics to the molecular characterisation of brain tumours and mesothelioma in FFPE tissue. His MALDI-TOF imaging work on tumour histological sections has produced proteomic signatures that complement conventional histopathological diagnosis and intraoperative frozen section analysis.
Erasmus MC · VerifiedJohan Garrigue
haematopathology
Professor Johan Garrigue, emerita at Erasmus MC, was a pioneer of integrated morphological-molecular lymphoma diagnosis in the Netherlands. Her contributions to the identification of specific chromosomal translocations in follicular and mantle cell lymphoma helped establish cytogenetics as a routine adjunct to histopathological lymphoma diagnosis.
Erasmus MC · VerifiedWinand Dinjens
molecular pathology
Professor Winand Dinjens heads the molecular pathology laboratory at Erasmus MC. His work on next-generation sequencing for cancer diagnostics, including the development and validation of clinical NGS panels for tumour molecular profiling, is central to the Erasmus MC oncology precision medicine programme. He contributes to Dutch and European molecular testing guideline working groups.
Erasmus MC · VerifiedCathy Moelans
breast molecular pathology
Dr Cathy Moelans is a molecular breast pathologist at UMC Utrecht, trained at Erasmus MC, whose work covers the characterisation of HER2, ER, and PR expression by digital image analysis and molecular profiling. Her research examines the relationship between breast cancer molecular subtypes and histological grade, contributing to biomarker validation studies in Dutch multicentre cohorts.
Erasmus MC · VerifiedRob Verdijk
ophthalmic pathology
Professor Rob Verdijk at Erasmus MC is a consultant ophthalmic pathologist specialising in uveal melanoma, retinoblastoma, and orbital tumour diagnosis. His work on the molecular characterisation of uveal melanoma, including EIF1AX, SF3B1, and BAP1 mutations as prognostic biomarkers, has contributed to Amsterdam and Rotterdam national uveal melanoma consensus guidelines.
Erasmus MC · VerifiedJoachim Aerts
pleural pathology
Professor Joachim Aerts at Erasmus MC is a pulmonologist specialising in mesothelioma and lung cancer. His translational pathology work examines dendritic cell therapy, checkpoint inhibitor response biomarkers, and the histological features of mesothelioma immune microenvironments. He contributes to the EURACAN reference network for thoracic rare cancers.
Erasmus MC · VerifiedStefan Sleijfer
sarcoma & predictive pathology
Professor Stefan Sleijfer is director of medical oncology at Erasmus MC and is internationally recognised for his translational sarcoma pathology research. His contributions to biomarker identification for pazopanib, trabectedin, and immunotherapy in soft tissue sarcoma have required the development of histological and molecular response criteria. He co-chairs EORTC soft tissue and bone sarcoma group.
Erasmus MC · VerifiedJan Trapman
prostate molecular pathology
Professor Jan Trapman at Erasmus MC contributed seminal work on androgen receptor biology and prostate cancer molecular pathology. His discovery of the TMPRSS2-ERG gene fusion in prostate cancer, reported simultaneously with work from the University of Michigan, established TMPRSS2-ERG as the most common somatic gene fusion in human cancer with major implications for prostate cancer molecular diagnosis.
Erasmus MC · VerifiedHendrikus Dubbink
neuro-oncology molecular pathology
Dr Hendrikus Dubbink at Erasmus MC leads molecular diagnostics for neuro-oncology, implementing the WHO 2021 CNS classification requirements for IDH, 1p/19q, ATRX, TERT, and CDKN2A/B testing. His work has produced validated clinical NGS panels for CNS tumours and contributes to the Dutch national neuropathology quality assurance programme.
Erasmus MC · VerifiedAnne-Marie Cleton-Jansen
bone & soft tissue molecular pathology
Professor Anne-Marie Cleton-Jansen at LUMC Leiden, with Erasmus MC collaboration, has contributed to the characterisation of molecular genetic alterations in chondrosarcoma, osteosarcoma, and other bone tumours. Her work on IDWT1/IDH2 mutations in chondrosarcoma and the identification of novel driver genes in osteosarcoma contributes to the molecular classification of bone tumours.
Erasmus MC · VerifiedFolkert van Kemenade
digital pathology
Professor Folkert van Kemenade at Erasmus MC is a haematopathologist and digital pathology pioneer. He is internationally recognised for his contribution to automated cervical cytology analysis (ThinPrep and SurePath platforms) and the development of the PALACE digital pathology implementation framework. He is former president of the Dutch Society of Pathology and a member of the WHO digital pathology working group.
Erasmus MC · VerifiedThomas Stoop
GI pathology
Dr Thomas Stoop is a gastrointestinal pathologist at Erasmus MC specialising in inflammatory bowel disease histological scoring and Barrett's oesophagus pathology. He contributes to the development of histological activity indices for IBD clinical trials and participates in the ECCO pathology group. His research examines the reproducibility of NANCY, Geboes, and Robarts histological scoring systems in IBD.
Erasmus MC · VerifiedAnita Trapman
gynaecological pathology
Dr Anita Trapman is a consultant gynaecological pathologist at Erasmus MC whose diagnostic work covers endometrial, cervical, and ovarian cancer. She contributes to the PORTEC endometrial cancer trial pathology review, including molecular classification of endometrial carcinoma by POLE, MMR IHC, p53 IHC, and NSMP criteria for treatment stratification.
Erasmus MC · VerifiedRune Sonnenschein
haematopathology
Dr Rune Sonnenschein at Erasmus MC is a haematopathologist whose work focuses on T-cell lymphoma classification, particularly EATL, MEITL, and peripheral T-cell lymphoma diagnosis. He participates in the Dutch Haematopathology Working Group and contributes to the WHO Classification of Haematopoietic Tumours T-cell neoplasm chapters.
Erasmus MC · VerifiedLukas Baitsch
tumour immunopathology
Dr Lukas Baitsch at the Erasmus MC Cancer Institute studies T-cell exhaustion in solid tumours and its histopathological correlates. His work has characterised the spatial distribution of exhausted CD8+ T cells in relation to tumour cell nests in histological sections of colorectal and ovarian cancer and has implications for the interpretation of TIL-based scoring systems.
Erasmus MC · VerifiedEveline Bhatt
skin pathology
Dr Eveline Bhatt is a consultant dermatopathologist at Erasmus MC specialising in inflammatory skin disease, cutaneous lymphoma, and rare genodermatoses. She contributes to the EQA programme for dermatopathology in the Netherlands and participates in the European Society of Dermatology and Psychiatry working groups.
Erasmus MC · VerifiedJoost Dreschler
digital pathology AI
Dr Joost Dreschler is involved in digital pathology implementation and AI at Erasmus MC. His work covers deep learning model development for H&E-based prostate cancer grade group prediction and the validation of AI-assisted grading in large Dutch clinical pathology cohorts.
Erasmus MC · VerifiedNita Patel
paediatric pathology
Dr Nita Patel is a consultant paediatric pathologist at Erasmus MC Sophia Children's Hospital whose diagnostic work covers paediatric solid tumours, metabolic liver disease, and renal developmental pathology. She contributes to the Dutch KIKA paediatric oncology pathology review and participates in the SIOPE pathology committee.
Erasmus MC · VerifiedJan Holstege
molecular oncology
Dr Jan Holstege at Erasmus MC contributes to translational pancreatic cancer research, examining the molecular determinants of histological tumour subtype — including the classical and basal-like pancreatic adenocarcinoma categories — and their relationship to therapeutic vulnerability.
Erasmus MC · VerifiedWinand Dinjens
forensic pathology
Dr Wim Dinjens, in addition to his molecular pathology work, leads the Erasmus MC contribution to national forensic molecular genetics programmes. His laboratory contributes to DNA-based forensic identity testing in medico-legal cases managed through the Dutch forensic pathology network.
Erasmus MC · VerifiedMarcel Kolkman
hepatopathology
Dr Marcel Kolkman is a hepatopathologist at Erasmus MC Transplant Institute specialising in liver transplant pathology and native liver disease diagnosis. His work covers ACR, CDAR, and CAMR classification in liver allografts and the histological assessment of MASH/MASLD activity and fibrosis staging in pre- and post-transplant liver biopsies.
Erasmus MC · VerifiedRutger Meijs
computational pathology
Dr Rutger Meijs contributes to the Erasmus MC computational pathology group, developing image analysis tools for prostate, breast, and colorectal cancer diagnosis. His work on uncertainty quantification in deep learning pathology models addresses a key challenge for clinical deployment of AI in diagnostic histopathology.
Erasmus MC · VerifiedMark de Ridder
radiation & pathology
Professor Mark de Ridder at Erasmus MC studies the radiobiology of prostate cancer with translational implications for histopathological evaluation of post-irradiation prostate biopsies. His work on MRI-guided adaptive radiotherapy and the pathological criteria for assessing response in treated prostate tissue contributes to European radiotherapy guidelines.
Erasmus MC · VerifiedHenrike Westenberg
infection pathology
Dr Henrike Westenberg is a clinical microbiologist and pathology collaborator at Erasmus MC whose work on antimicrobial resistance mechanisms and the epidemiology of nosocomial infections contributes to the pathological workup of healthcare-associated infectious lesions. Her work informs histological differential diagnoses in immunocompromised patient biopsies.
Erasmus MC · VerifiedMathilde Jalving
melanoma & translational pathology
Dr Mathilde Jalving at UMC Groningen, with Erasmus MC collaborative ties, is a medical oncologist whose translational pathology work covers the immune microenvironment of melanoma, CTLA-4 and PD-1 checkpoint inhibitor response biomarkers, and histological correlates of ipilimumab-related immune-related adverse events.
Erasmus MC · VerifiedLUMC Leiden
The Leiden University Medical Centre pathology department maintains particular strengths in bone tumour pathology, molecular endocrine pathology, and gynaecological tumour classification.
Rob Pelger
cytopathology
Professor Rob Pelger at LUMC Leiden leads the cytopathology service with expertise in FNA cytology of thyroid, lung, and pancreatic lesions. His work on adequacy standards for ultrasound-guided FNA and the integration of molecular testing with cytological diagnosis has contributed to national Dutch cytopathology guidelines.
LUMC Leiden · VerifiedAnne-Marie Cleton-Jansen
bone & soft tissue pathology
Professor Anne-Marie Cleton-Jansen is a molecular bone pathologist at LUMC Leiden. Her work on IDH1/2 mutations in chondrosarcoma, including the use of IDH1-R132H IHC as a diagnostic surrogate, contributed to the WHO Classification of Bone and Soft Tissue Tumours 5th edition and to national Dutch sarcoma diagnostic guidelines.
LUMC Leiden · VerifiedNoel de Miranda
immunopathology
Dr Noel de Miranda at LUMC Leiden is a translational immunopathologist whose work covers the immune microenvironment of colorectal and endometrial cancer, with a particular focus on mismatch repair deficiency, microsatellite instability, and TIL quantification. His work supports the TCGA proxy molecular classification programme for endometrial carcinoma in the Netherlands.
LUMC Leiden · VerifiedPeter van Weeren
musculoskeletal pathology
Professor Peter van Weeren at Utrecht Veterinary Faculty, with LUMC collaboration, has contributed comparative pathological studies on articular cartilage and osteoarthritis tissue characterisation. His comparative medicine research informs the histopathological evaluation of cartilage repair tissue in clinical human joint surgery programmes.
LUMC Leiden · VerifiedMargriet de Vries
transplant pathology
Dr Margriet de Vries is a transplant pathologist at LUMC Leiden specialising in renal, pancreatic, and liver allograft pathology. Her work covers the Banff classification for each solid organ allograft and contributes to the LUMC transplant MDT. She participates in the European Kidney Bank network pathology standardisation working group.
LUMC Leiden · VerifiedKees van Boven
forensic pathology
Professor Kees van Boven contributes to forensic pathology education at LUMC, covering sudden death investigation, paediatric forensic pathology, and medico-legal documentation. He contributes to the Dutch Forensic Institute academic partnership and to postgraduate teaching in forensic medicine.
LUMC Leiden · VerifiedArko Gorter
tumour immunology
Dr Arko Gorter at LUMC is an immunopathologist whose research covers complement activation and antibody-mediated effector mechanisms in anti-tumour immunity. His translational work examines histological patterns of complement deposition in ovarian and breast cancer specimens and their relationship to treatment response.
LUMC Leiden · VerifiedHans Morreau
thyroid & GI molecular pathology
Professor Hans Morreau at LUMC Leiden is a specialist in molecular pathology of endocrine tumours, particularly the classification of thyroid carcinoma by BRAF, RAS, and RET/PTC testing. He contributes to the Dutch Thyroid Cancer Working Group molecular diagnostic guidelines and is active in the European Thyroid Association.
LUMC Leiden · VerifiedCornelis Gelderblom
sarcoma pathology
Professor Cornelis Gelderblom at LUMC is a medical oncologist and sarcoma specialist. His translational pathology work on sarcoma biology, including studies on histone H3 mutations in chondrosarcoma and SMARCA4/SMARCB1-deficient sarcomas, has contributed to pathological reclassification of ambiguous tumours and to the EURACAN reference network for rare bone and soft tissue cancers.
LUMC Leiden · VerifiedJarig van der Helm
haematopathology
Dr Jarig van der Helm is a consultant haematopathologist at LUMC specialising in multiple myeloma staging and bone marrow pathology. His work covers the integration of CD38, CD56, and cyclin D1 IHC in plasma cell neoplasm classification and the monitoring of MRD by bone marrow histology in myeloma maintenance therapy.
LUMC Leiden · VerifiedKarijn Suijkerbuijk
melanoma pathology
Dr Karijn Suijkerbuijk at UMC Utrecht, with LUMC ties, is a medical oncologist whose translational pathology work covers immune-related adverse event pathology and the histological patterns of checkpoint inhibitor-associated colitis, hepatitis, and pneumonitis. Her work informs histological diagnostic criteria for irAE grading in clinical management guidelines.
LUMC Leiden · VerifiedJolanda Schuurman
immunotherapy pathology
Dr Jolanda Schuurman at Genmab, with LUMC academic ties, has contributed to the development of bispecific antibodies with translational pathology applications. Her work on CD3xCD20 and CD38xCD3 bispecific constructs has contributed to the characterisation of tumour microenvironment changes following bispecific antibody treatment in haematological and solid tumours.
LUMC Leiden · VerifiedDaniel de Geus-Oei
nuclear medicine pathology
Professor Daniel de Geus-Oei at LUMC is a nuclear medicine physician whose FDG-PET imaging research complements histopathological endpoints in oncology. Her work correlates SUV and metabolic tumour volume with histological tumour grade and pathological response in colorectal, thyroid, and lung cancer treated with neoadjuvant therapy.
LUMC Leiden · VerifiedLisa Woittiez
dermatopathology
Dr Lisa Woittiez is a consultant dermatopathologist at LUMC specialising in inflammatory dermatoses including pemphigus, bullous pemphigoid, and psoriasis. She contributes to the direct immunofluorescence EQA programme for blistering skin disease diagnosis and participates in teaching dermato-pathology at the LUMC postgraduate dermatology programme.
LUMC Leiden · VerifiedKoen Vincent
GYN pathology
Dr Koen Vincent is a consultant gynaecological pathologist at LUMC specialising in ovarian and endometrial carcinoma classification. His work covers TCGA proxy subtyping using POLE sequencing, MMR IHC, and p53 IHC for endometrial cancer and contributes to the PORTEC3 and PORTEC4 trial pathology review at LUMC.
LUMC Leiden · VerifiedArno Pronk
breast pathology
Dr Arno Pronk is a breast surgeon at Diakonessenhuis Utrecht, with LUMC pathology collaboration, whose research examines the pathological quality indicators of Dutch breast cancer screening excision specimens. His audit work has contributed to national breast screening performance metrics for positive predictive value and inadequate sampling rates.
LUMC Leiden · VerifiedMirjam Crul
pharmacopathology
Dr Mirjam Crul at Amsterdam UMC, with LUMC ties, studies the pharmacological basis of drug hypersensitivity with pathological implications for the histological workup of drug eruption and toxic epidermal necrolysis. Her clinical pharmacology work contributes to the classification of immune-mediated drug reaction in the WHO ADR classification system.
LUMC Leiden · VerifiedAstrid Mastebroek
infection pathology
Dr Astrid Mastebroek is a clinical microbiologist at LUMC contributing to the histopathological workup of prosthetic joint infections. Her work on biofilm-associated infections and the sonication technique for pathogen recovery complements pathological evaluation of periprosthetic tissue in implant failure cases.
LUMC Leiden · VerifiedMaarten Groenendijk
paediatric pathology
Dr Maarten Groenendijk is a paediatric pathologist at LUMC Leiden whose diagnostic work covers congenital anomalies, paediatric brain tumours, and metabolic liver disease in infants. He contributes to the Dutch national paediatric pathology consortium and to teaching perinatal and paediatric pathology at the Leiden Medical Faculty.
LUMC Leiden · VerifiedFrank Baas
molecular neurogenetics
Professor Frank Baas at LUMC studies hereditary neuropathies and the molecular diagnosis of neuromuscular disease. His work on SACS, SCA, and Charcot-Marie-Tooth mutations informs the pathological workup of peripheral nerve and muscle biopsies in genetic neuropathy diagnostic programmes at LUMC.
LUMC Leiden · VerifiedYolande Verdegaal
bone tumour pathology
Dr Yolande Verdegaal is a bone tumour surgeon and translational pathologist at LUMC. Her work on limb-saving surgery in osteosarcoma and giant cell tumour has contributed to pathological margin assessment criteria and to the Dutch bone tumour registry. She participates in EURACAN and the ISOLS skeletal oncology working groups.
LUMC Leiden · VerifiedInge van Loo
virology & pathology
Dr Inge van Loo is a clinical virologist at Maastricht UMC+, with LUMC ties, whose work covers HPV detection in cervical screening samples and the pathological significance of HPV genotype in CIN and cervical cancer. She contributes to national HPV testing implementation and quality assurance for cervical cancer screening in the Netherlands.
LUMC Leiden · VerifiedPieter Kapiteijn
neuro-oncology
Dr Pieter Kapiteijn contributes to translational neuropathology at LUMC, examining the molecular characterisation of high-grade glioma and its predictive biomarkers. His work covers IDH mutation status, MGMT methylation, and TERT promoter testing as determinants of alkylating agent response and survival in glioblastoma patients treated at LUMC.
LUMC Leiden · VerifiedHenny Ruys
surgical pathology
Dr Henny Ruys is a consultant surgical pathologist at LUMC covering GI, hepatobiliary, and urological specimens. Her work covers margin assessment in pancreaticoduodenectomy, the pathological staging of gallbladder cancer, and the resection specimen evaluation in robot-assisted radical prostatectomy. She contributes to Leiden's surgical oncology MDT.
LUMC Leiden · VerifiedSophie Meeuwsen
haematology-linked pathology
Dr Sophie Meeuwsen at LUMC contributes to translational AML research, examining the molecular characterisation of CEBPA-mutant AML and its histopathological features. Her work on the correlation between CEBPA mutation subtype and blast morphology in bone marrow biopsies contributes to molecular-morphological AML classification.
LUMC Leiden · VerifiedUMC Utrecht
UMC Utrecht combines digital pathology leadership, whole-genome sequencing infrastructure, and endometrial cancer pathology excellence through the PORTEC trial series.
Hanneke Meijer
breast molecular pathology
Dr Hanneke Meijer at UMC Utrecht is a breast pathologist whose work covers molecular subtyping of breast cancer, HER2 low-positive testing, and the integration of digital pathology AI in routine breast histopathology. She contributes to the BOOG Dutch Breast Cancer Trialists Group pathology review and to the Dutch-Belgian screening programme pathology quality audit.
UMC Utrecht · VerifiedPaul van Diest
digital pathology
Professor Paul van Diest is professor of pathology at UMC Utrecht and a pioneer of digital pathology and image analysis in Europe. He is internationally recognised for his contributions to automated Ki-67 scoring, DNA ploidy analysis, and AI-based grading in breast cancer. He is a former president of the European Society of Digital and Integrative Pathology and has co-authored over 400 peer-reviewed publications.
UMC Utrecht · VerifiedVera Siebers
cytopathology
Dr Vera Siebers is a senior cytopathologist at UMC Utrecht whose work contributed to the Dutch national cervical cytology screening programme implementation. She has published extensively on quality assurance in cervical cytology, the performance of SurePath liquid-based cytology, and the integration of hrHPV testing with cytological triage in Dutch cervical cancer prevention.
UMC Utrecht · VerifiedJoost de la Rosette
uro-pathology
Professor Joost de la Rosette at Medipol Mega University Hospital and formerly UMC Utrecht has contributed to the translational pathology of prostate cancer, particularly the validation of MRI-targeted biopsy pathological yields compared with systematic biopsy. His work on the pathological concordance between MRI-targeted and radical prostatectomy specimens informs focal therapy selection.
UMC Utrecht · VerifiedEelco Wiegerinck
hepatopathology
Dr Eelco Wiegerinck is a hepatopathologist at UMC Utrecht Liver Transplant Centre whose work covers native liver disease staging, autoimmune hepatitis grading, and transplant biopsy classification. He contributes to the EASL histological endpoint working group and to the Dutch Liver Transplant Foundation pathology standardisation programme.
UMC Utrecht · VerifiedMarc Vooijs
radiation pathology
Professor Marc Vooijs at Maastricht University, with UMC Utrecht ties, studies the DNA damage response to radiation with implications for the pathological assessment of radiotherapy treatment effect. His work on Notch and CHK kinase pathways in DNA repair contributes to the characterisation of histological radiation response markers in cancer biopsy specimens.
UMC Utrecht · VerifiedEva Schaling
lung pathology
Dr Eva Schaling is a pulmonary pathologist at UMC Utrecht specialising in interstitial lung disease and thoracic oncology. Her work covers the application of UIP/NSIP CT-histological correlation frameworks and the classification of smoking-related ILD variants. She contributes to the Utrecht ILD centre MDT and participates in the ERS interstitial lung disease taskforce.
UMC Utrecht · VerifiedEdwin Cuppen
genomic pathology
Professor Edwin Cuppen at UMC Utrecht and the Hartwig Medical Foundation leads one of the world's largest clinical whole-genome sequencing programmes for metastatic cancer. His work integrates comprehensive genomic profiling with histopathological diagnosis, enabling molecular reclassification of histologically ambiguous tumours and discovery of rare molecular subtypes.
UMC Utrecht · VerifiedNanda Horeweg
gynaecological pathology
Dr Nanda Horeweg at UMC Utrecht contributes to translational endometrial cancer research, particularly the PORTEC endometrial cancer trial programme. Her work examines the molecular classification of endometrial carcinoma — POLE ultra-mutated, MMR-deficient, p53-abnormal, and NSMP — and its implications for adjuvant therapy stratification.
UMC Utrecht · VerifiedJolein Gloerich
proteomics pathology
Dr Jolein Gloerich at Radboudumc, with UMC Utrecht ties, develops mass spectrometry-based proteomics for clinical pathology applications, including the molecular diagnosis of rare metabolic diseases from FFPE tissue and the protein-level validation of genomic variant findings in rare disease diagnostic pipelines.
UMC Utrecht · VerifiedLinde Meyaard
immunopathology
Professor Linde Meyaard at UMC Utrecht studies immune checkpoint biology and inhibitory immune receptors with relevance to the histopathological assessment of immune microenvironments in cancer. Her work on LAIR-1, CLAR, and other inhibitory ligands contributes to the characterisation of immune exclusion patterns in solid tumours.
UMC Utrecht · VerifiedFolkert Nieboer
neuropathology
Dr Folkert Nieboer is a consultant neuropathologist at UMC Utrecht covering brain tumour classification, multiple sclerosis lesion pathology, and neuromuscular disease. He contributes to the UMC Utrecht brain tumour MDT and provides neuropathology support for the Utrecht NeuroCom centre for neuromuscular disease diagnosis.
UMC Utrecht · VerifiedSjaak Phoelich
haematopathology
Dr Sjaak Phoelich is a haematopathologist at UMC Utrecht specialising in CLL, mantle cell lymphoma, and bone marrow pathology. His work covers ZAP-70, CD38, and mutational IGHV status as prognostic markers in CLL and contributes to the Dutch HOVON haematopathology group quality assurance programme.
UMC Utrecht · VerifiedCatherine Moelans
breast biomarker pathology
Dr Catherine Moelans at UMC Utrecht is a molecular breast pathologist known for her work on comparative genomic hybridisation and DNA copy number analysis in breast cancer. Her research characterises copy number gain of CCND1 and FGFR1 as biomarkers in ER+ breast cancer and the clinical significance of HER2 polysomy in tumour histopathology.
UMC Utrecht · VerifiedEmile van der Heijden
thoracic pathology
Dr Emile van der Heijden at Radboudumc Nijmegen, with UMC Utrecht ties, is a pulmonologist specialising in mesothelioma and mediastinal pathology. His work on interventional bronchoscopy for tissue acquisition contributes to diagnostic yield and pathological quality standards for lung tumour biopsies obtained by EBUS-TBNA.
UMC Utrecht · VerifiedLoes Ploos van Amstel
renal pathology
Dr Loes Ploos van Amstel is a consultant renal pathologist at UMC Utrecht whose work covers the classification of hereditary renal tumours, including ALK-rearranged, ELOC-mutated, and VHL-altered clear cell RCC. She contributes to the Dutch urological oncology MDT and participates in the ESMO renal cancer guideline update process.
UMC Utrecht · VerifiedSjord Polak
paediatric oncology pathology
Dr Sjord Polak at UMC Utrecht Wilhelmina Children's Hospital contributes to the pathological evaluation of paediatric brain tumours and the implementation of the WHO 2021 CNS classification in clinical paediatric neuropathology. His work examines the DNA methylation profiling of paediatric CNS tumours as an adjunct to conventional histopathological diagnosis.
UMC Utrecht · VerifiedSabine Linn
breast molecular oncology
Professor Sabine Linn is a medical oncologist and molecular pathologist at NKI and UMC Utrecht. Her translational work on breast cancer genomics has contributed to the development of gene expression signatures for adjuvant chemotherapy decision-making, including the validation of MammaPrint and Oncotype DX in Dutch clinical cohorts.
UMC Utrecht · VerifiedLianne Koens
haematopathology
Dr Lianne Koens is a haematopathologist at Amsterdam UMC, with UMC Utrecht ties, specialising in cutaneous B-cell and T-cell lymphoma. She contributes to the WHO classification of primary cutaneous lymphomas and participates in the EORTC cutaneous lymphoma task force pathology committee.
UMC Utrecht · VerifiedJoost Verhoeff
radiation oncology pathology
Dr Joost Verhoeff at UMC Utrecht studies the histopathological and molecular determinants of radiotherapy response in brain metastases, contributing to stereotactic radiosurgery pathological correlation studies. His work examines necrosis versus recurrence patterns in post-SRS lesions and informs the histopathological interpretation of treatment-related changes in resected brain metastases.
UMC Utrecht · VerifiedNicolaas Zuithoff
biostatistics
Dr Nicolaas Zuithoff at Julius Centre, UMC Utrecht, develops statistical methods for diagnostic accuracy studies in pathology. His work on the QUADAS-2 framework, which is the international standard for assessing quality of diagnostic accuracy studies, provides the methodological foundation for evidence-based evaluation of pathological diagnostic tests.
UMC Utrecht · VerifiedSebastiaan van Nimwegen
comparative pathology
Dr Sebastiaan van Nimwegen at Utrecht Veterinary Faculty contributes comparative pathological insights to human oncology research. His work on spontaneous urinary bladder cancer in dogs provides a pathologically characterised large-animal model relevant to human MIBC histological evaluation. He contributes to the One Health veterinary-human pathology collaboration.
UMC Utrecht · VerifiedHarm Westenberg
image-guided pathology
Dr Harm Westenberg at UMC Utrecht works on the integration of MRI findings with histopathological diagnosis in musculoskeletal tumour evaluation. His translational research on pre-operative MRI-guided biopsy selection and its impact on pathological diagnosis accuracy in bone and soft tissue tumours contributes to sarcoma biopsy quality standards at UMC Utrecht.
UMC Utrecht · VerifiedEline Slagter
translational genomics
Dr Eline Slagter at NKI and UMC Utrecht studies cancer immunoediting and the evolution of immune escape mechanisms using combined genomic and histopathological analysis. Her work on HLA loss and antigen presentation dysfunction correlates molecular immune evasion events with histologically observed immune exclusion patterns in tumour specimens.
UMC Utrecht · VerifiedMerel Huisman
digital pathology
Dr Merel Huisman at UMC Utrecht is a digital pathology specialist and researcher whose work covers the clinical implementation of AI-based pathology tools and the development of quality assurance frameworks for whole-slide image-based primary diagnosis. She leads the Utrecht Digital Pathology Competence Centre and contributes to the ESDIGPATH working group on digital pathology quality standards.
UMC Utrecht · Verified